Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non- Hodgkin lymphoma

Cancer Genetics and Cytogenetics

Volumn 108, Issue 2, 1999, Pages 120-126

  Dave, Bhavana J ^a   Pickering, Diane L ^a   Hess, Michelle M ^a   Weisenburger, Dennis D ^b   Armitage, James O ^c   Sanger, Warren G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN;

ARTICLE; CANCER GENETICS; CHROMOSOME 1P; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; HUMAN; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 1; CYCLIN-DEPENDENT KINASES; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, NON-HODGKIN; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0033555710     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00138-1     Document Type: Article

References (42)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin. 47:1997;5-27.
2. Levine E.G., Bloomfield C.D. Cytogenetics of non-Hodgkin's lymphoma. J Natl Cancer Inst Monogr. 10:1990;7-12.
3. LeBeau M.M. Chromosomal abnormalities in non-Hodgkin's lymphomas. Semin Oncol. 17:1990;20-29.
4. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet. 15:1997;417-474.
5. Yunis J.J., Oken M.M., Kaplan M.E., Ensrud K.M., Howe R.B., Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med. 307:1982;1231-1236.
6. Mitelman F. Catalog of Chromosome Aberrations in Cancer. 5:1994;Wiley-Liss, New York.
7. Mrozek K., Bloomfield C.D. New recurrent structural chromosome aberrations in non-Hodgkin's lymphoma. a review of the published literature Int J Oncol. 8:1996;851-858.
8. Nowell P.C., Croce C.M. Chromosome translocations and oncogenes in human lymphoid tumors. Am J Clin Pathol. 94:1990;229-237.
9. Dalla-Favera R. Chromosomal translocations involving the c-myc oncogene in lymphoid neoplasia. Kirsch I.R. The Causes and Consequences of Chromosomal Aberrations. 1991;313-332 CRC Press, Boca Raton.
10. Croce C.M. Molecular biology of lymphomas. Semin Oncol. 20:1993;31-46.
11. Stanbridge E.J. Functional evidence for human tumor suppressor genes. chromosome and molecular genetic studies Cancer Surv. 12:1992;5-24.
12. Knudson A.G. Mutation and cancer. a personal Odyssey Adv Cancer Res. 67:1995;1-23.
13. Atkin N.B. Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet. 21:1986;279-285.
14. Heim S., Mitelman F. Cancer Cytogenetics. 1995;Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Wiley-Liss, New York, pp. 266-309.
15. Dave B.J., Hopwood V.L., King T.M., Ziang H., Spitz M.R., Pathak S. Genetic susceptibility to lung cancer as determined by lymphocyte chromosomal analysis. Cancer Epidemiol Biomarkers Prev. 4:1995;743-749.
16. Dave B.J., Hsu T.C., Hong W.K., Pathak S. Nonrandom distribution of chromosome breaks in patients with different malignancies. Int J Oncol. 5:1994;733-740.
17. Schwab M., Cristian P., Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosom Cancer. 16:1996;211-229.
18. Dave BJ, Hess MM, Pickering DL, Zaleski DH, Pfeifer AL, Weisenburger DD, Armitage JO, Sanger WG (submitted): Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
19. Lahti J.M., Valentine M., Xiang J., Jones B., Amann J., Grenet J., Richmond G., Look A.T., Kidd V.J. Alterations in PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet. 7:1994;370-375.
20. Elipers P.G., Barnoski B.L., Han J., Carroll A.J., Kidd V.J. Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15. Genomics. 11:1991;621-629.
21. The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 49:1982;2112-2135.
22. Sanger W.G., Armitage J.O., Bridge J.A., Weisenburger D.D., Fordyce-Boyer R., Purtilo D.T. Initial and subsequent cytogenetic studies in malignant lymphoma. Cancer. 60:1987;3014-3019.
23. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
24. Juneja S., Lukeis R., Tan L., Cooper I., Szelag G., Parkin J.D., Ironside P., Garson O.M. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma. nonrandom chromosomal abnormalities and histological correlations Br J Haematol. 76:1990;231-237.
25. Hammond D.W., Goepel J.R., Aitken M., Hancock B.W., Potter A.M., Goyns M.H. Cytogenetic analysis of a United Kingdom series of non-Hodgkin's lymphomas. Cancer Genet Cytogenet. 61:1992;31-38.
26. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., Mckeeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other cancers. Cell. 90:1997;809-819.
27. White P.S., Kaufman B.A., Marshall H.N., Brodeur G.M. Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma. Genes Chromosom Cancer. 7:1993;102-108.
28. Enomoto H., Ozaki T., Takahashi E., Nomura N., Tabata S., Takahashi H., Ohnuma N., Tanabe M., Iwai J., Yoshida H., Matsunaga T., Sakiyama S. Identification of human DAN gene mapping to the putative neuroblastoma tumor suppressor locus. Oncogene. 9:1994;2785-2791.
29. Ellmeir W., Aguzzi A., Kleiner E., Kurzbauer R., Weith A. Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development. EMBO J. 11:1992;2563-2571.
30. Offit K., Wong G., Filippa D.A., Tao Y., Chaganti R.S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma. clinical correlations Blood. 77:1991;1508-1515.
31. Kristofferson U., Heim S., Mandahl N., Olsson H., Ranstam J., Akerman M., Mitelman F. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin's lymphoma. Cancer Genet Cytogenet. 25:1987;55-64.
32. Whang-Peng J., Knutsen T., Jaffe E.S., Steinberg S.M., Raffeld M., Zhao W.P., Duffey P., Condron K., Yano T., Longo D.L. Sequential analysis of 43 patients with non-Hodgkin's lymphoma. clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies Blood. 85:1995;203-216.
33. Levine E.G., Arthur D.C., Frizzera G., Peterson B.A., Hurd D.A., Bloomfield C.D. Cytogenetic abnormalities predict clinical out-come in non-Hodgkin's lymphoma. Ann Intern Med. 108:1988;14-20.
34. Offit K., Richardson M., Chen Q., Hampton A., Koduru P., Jhanwar S., Filippa D., Leiberman P., Clarkson B.D., Chaganti R.S.K. Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. Cancer Genet Cytogenet. 37:1989;85-93.
35. Christiansen H., Delattre O., Fuchs S., Theobald M., Christiansen N.M., Berthold F., Lampert F. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas. results of the German Neuroblastoma study group Prog Clin Biol Res. 385:1994;19-25.
36. Versteeg R., Caron H., Cheng N.C., van der Drift P., Slater R., Westerveld A., Voute P.A., Delattre O., Laureys G., Van Roy N., Speleman F. 1p36. every subband a suppressor? Eur J Cancer. 31A:1995;538-541.
37. White P.S., Maris J.M., Beltinger C., Sulman E., Marshall H.N., Fujimori M., Kaufman B.A., Beigel J.A., Allen C., Hilliard C., Valentine M.B., Look A.T., Enomoto H., Sakiyama S., Brodeur G.M. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA. 92:1995;5520-5524.
38. Dracopoli N.C., Harnette P., Bale S.J., Stanger B.Z., Tucker M.A., Housman D.E., Kefford R.F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA. 86:1989;4614-4618.
39. Mathew C.C.G., Smith B.A., Thorpe K., Wong Z., Royle N.J., Jeffreys A.J., Ponder B.A. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature. 328:1987;524-526.
40. Bardi G., Pandis C., Fenger C., Kronborg O., Bomme L., Heim S. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res. 53:1993;1895-1898.
41. Thompson F.H., Taetle R., Trent J.M., Liu Y., Massey-Brown K., Scott K.M., Weinstein R.S., Emerson J.C., Alberts D.S., Nelson M.A. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genet Cytogenet. 96:1997;106-110.
42. Tanaka K., Yanoshita R., Konishi M., Oshimura M., Maeda Y., Mori T., Miyaki M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene. 8:1993;2253-2258.